Vellore Institute of Technology, Vellore
+91-9842660673
sbrtganga@gmail.com or drpnramesh@gmail.com

About Us

Overview

Bacteriophages were discovered about a century ago by two independent scientists, Frederick Twort in 1915 and Felix d’Herelle in 1917. Later in 1919, d’Herelle started using phages to cure bacterial diseases, but the concept did not take off due to practical difficulties. Phages work as antimicrobial agents against pathogenic bacteria, which makes them unique. In the era of antibiotic resistance, it can make a revolution in medicine. The bacteriophages are naturally present in the environment and are the most abundant organism on Earth. The arousal of MDR, XDR and PDR bacteria created a panic situation globally that can be overcome by life-saving bacteriophage therapy. Recent clinical evidence proves that phages can effectively kill the superbugs that the last line antibiotics fail. It has many pros as it can be effective against both antibiotic-sensitive and -resistant pathogens, it can be used as monotherapy or along with antibiotics, easy to isolate phages from natural sources, and it can be used as a cocktail for multiple infections. Society for Bacteriophage Research and Therapy (SBRT) was established to promote the studies of bacteriophages in various fields. We aim to spread the goodness of phages in medicine, biotechnology, and environmental studies by holding hands with eminent scientists and researchers working in phages to create a healthy tomorrow. Our society works as a team with bacteriophage research experts from India. We effectively are working on the phages as they could be promising benefits shortly. Our society is conducting international conferences which aim to bring collaborative research networking across the globe. We also conduct webinars on phage research using eminent speakers to spread awareness about phage therapy and its application in the medical field. Our SBRT offers annual and lifetime memberships for the members. We encourage the willing people to join our hands to combat drug-resistant bacteria with the novel bacteriophages as therapeutic tools.

Dr. Ramesh N